| Literature DB >> 30609404 |
Zornitza Stark1, Lena Dolman2, Teri A Manolio3, Brad Ozenberger4, Sue L Hill5, Mark J Caulfied6, Yves Levy7, David Glazer8, Julia Wilson9, Mark Lawler10, Tiffany Boughtwood11, Jeffrey Braithwaite12, Peter Goodhand2, Ewan Birney13, Kathryn N North14.
Abstract
Genomic sequencing is rapidly transitioning into clinical practice, and implementation into healthcare systems has been supported by substantial government investment, totaling over US$4 billion, in at least 14 countries. These national genomic-medicine initiatives are driving transformative change under real-life conditions while simultaneously addressing barriers to implementation and gathering evidence for wider adoption. We review the diversity of approaches and current progress made by national genomic-medicine initiatives in the UK, France, Australia, and US and provide a roadmap for sharing strategies, standards, and data internationally to accelerate implementation.Mesh:
Year: 2019 PMID: 30609404 PMCID: PMC6323624 DOI: 10.1016/j.ajhg.2018.11.014
Source DB: PubMed Journal: Am J Hum Genet ISSN: 0002-9297 Impact factor: 11.025